Literature DB >> 2850474

Complete nucleotide sequence of a mouse VL30 retro-element.

S E Adams1, P D Rathjen, C A Stanway, S M Fulton, M H Malim, W Wilson, J Ogden, L King, S M Kingsman, A J Kingsman.   

Abstract

The complete nucleotide sequence of a mouse retro-element is presented. The cloned element is composed of 4,834 base pairs (bp) with long terminal repeats of 568 bp separated by an internal region of 3,698 bp. The element did not appear to have any open reading frames that would be capable of encoding the functional proteins that are normally produced by retro-elements. However, some regions of the genome showed some homology to retroviral gag and pol open reading frames. There was no region in VL30 corresponding to a retroviral env gene. This implies that VL30 is related to retrotransposons rather than to retroviruses. The sequence also contained regions that were homologous to known reverse transcriptase priming sites and viral packaging sites. These observations, combined with the known transcriptional capacity of the VL30 promoter, suggest that VL30 relies on protein functions of other retro-elements, such as murine leukemia virus, while maintaining highly conserved cis-active promoter, packaging, and priming sites necessary for its replication and cell-to-cell transmission.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850474      PMCID: PMC363524          DOI: 10.1128/mcb.8.8.2989-2998.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Structure of 50 to 70S RNA from Moloney sarcoma viruses.

Authors:  J Maisel; W Bender; S Hu; P H Duesberg; N Davidson
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

2.  Rescue of endogenous 30S retroviral sequences from mouse cells by baboon type C virus.

Authors:  S A Sherwin; U R Rapp; R E Benveniste; A Sen; G J Todaro
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

3.  Identification of a 30S RNA with properties of a defective type C virus in murine cells.

Authors:  R S Howk; D H Troxler; D Lowy; P H Duesberg; E M Scolnick
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

4.  Heterogeneity of "virus-like" genes encoding retrovirus-associated 30S RNA and their organization within the mouse genome.

Authors:  E Keshet; Y Shaul; J Kaminchik; H Aviv
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

5.  Defective retrovirus-like 30S RNA species of rat and mouse cells are infectious if packaged by type C helper virus.

Authors:  E M Scolnick; W C Vass; R S Howk; P H Duesberg
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

6.  Virus-like 30S RNA in mouse cells.

Authors:  P Besmer; U Olshevsky; D Baltimore; D Dolberg; H Fan
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

7.  Mating signals control expression of mutations resulting from insertion of a transposable repetitive element adjacent to diverse yeast genes.

Authors:  B Errede; T S Cardillo; F Sherman; E Dubois; J Deschamps; J M Wiame
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

8.  Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus.

Authors:  R W Ellis; D DeFeo; J M Maryak; H A Young; T Y Shih; E H Chang; D R Lowy; E M Scolnick
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue.

Authors:  D R Roop; D R Lowy; P E Tambourin; J Strickland; J R Harper; M Balaschak; E F Spangler; S H Yuspa
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

View more
  20 in total

1.  Avian endogenous retrovirus EAV-HP shares regions of identity with avian leukosis virus subgroup J and the avian retrotransposon ART-CH.

Authors:  M A Sacco; D M Flannery; K Howes; K Venugopal
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 2.  Normal and pathological functions of mammalian retroelements.

Authors:  Albert Deisseroth
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

3.  Functional heterogeneity of a large family of human LTR-like promoters and enhancers.

Authors:  A Feuchter; D Mager
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

4.  Proteolytic processing of pol-TYB proteins from the yeast retrotransposon Ty1.

Authors:  D J Garfinkel; A M Hedge; S D Youngren; T D Copeland
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function.

Authors:  N Tanese; A Telesnitsky; S P Goff
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Autonomous expression of RTVL-H endogenous retroviruslike elements in human cells.

Authors:  D A Wilkinson; J D Freeman; N L Goodchild; C A Kelleher; D L Mager
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

7.  Isolation and characterization of glucocorticoid- and cyclic AMP-induced genes in T lymphocytes.

Authors:  M T Harrigan; G Baughman; N F Campbell; S Bourgeois
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

8.  Isolation of virus-like (VL30) elements from the Q10 and D regions of the major histocompatibility complex.

Authors:  Y C Choi; D Meruelo
Journal:  Biochem Genet       Date:  1991-02       Impact factor: 1.890

9.  Sequence analysis of Mus dunni endogenous virus reveals a hybrid VL30/gibbon ape leukemia virus-like structure and a distinct envelope.

Authors:  G Wolgamot; L Bonham; A D Miller
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Inducible and cell type-specific expression of VL30 U3 subgroups correlate with their enhancer design.

Authors:  M Nilsson; S Bohm
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.